2-(2,5-Difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

Tris[4-(5-bromothiophen-2-yl)phenyl]amine>98.0%(HPLC)(N)200mg

N-(tert-Butoxycarbonyl)-L-cysteine methyl ester, 97.0%, 100g

Butanedioic acid, compd. with 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide (1:1), 98.50%, 5g

(4S)-4-METHYL-1,2,3-OXATHIAZOLIDINE 2,2-DIOXIDE, 95%, 100mg

1-(3-(5-Oxo-1-phenyl-2-thioxoimidazolidin-4-yl)propyl)guanidine hydrochloride, 98%, 10mg

Boc-(�)-trans-4-(6-methoxy-3-pyridinyl)pyrrolidine-3-carboxylic acid, 99.0%, 250mg

Butyl decanoate, 98%, 100g

1,3-Dibutyl-2-thiourea, 97%, 100g

4-Chloro-3-(trifluoromethyl)pyridine, 98.0%, 250mg

1-BOC-2-(CYANOMETHYL)PYRROLIDINE, 97.0%, 5g

(1R)-1-(5-FLUORO-2-IODOPHENYL)ETHAN-1-OL, 95%, 25g

1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95.0%, 5g